IRVINGTON, NY -- (MARKET WIRE) -- January 31, 2007 -- Electro-Optical Sciences, Inc. (“EOS”) (NASDAQ: MELA) today announced the initiation of the pivotal clinical trial for MelaFind®, the company’s non-invasive, point-of-care instrument to assist in the early diagnosis of melanoma.
